semaglutide and nonarteritic anterior ischemic optic neuropathy A recent Veterans Health Administration–based target trial emulation evaluated the incidence of (NAION) among adults with type 2 diabetes initiating compared with those initiating an SGLT2 This retrospective study suggests a

K.PossamaiL.et al (2018)

Many patients explore hepatoprotective supplements alongside prescribed medications, including weight-management peptides

Ongoing trials aim to clarify: Cardiovascular safety Long-term weight durability Role in prediabetes and non-diabetic populations Comparison to semaglutide and tirzepatide Until then, we continue to emphasize current best practices: lifestyle support, personalized nutrition, advanced lipid testing, and thoughtful pharmacotherapy

Your provider should establish a monitoring protocol before initiation and reassess at regular intervals

10.3390/ijms22105063 266 SolfaineR.MunirohL.SadarmanA.IrawanA

Its often used to address deficiencies in B12, which can lead to fatigue, anemia, and neurological symptoms